Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American Ancestry

Schizophrenia Research

Volumn 120, Issue 1-3, 2010, Pages 87-94

  Jiménez Castro, Lorena ^a,b   Hare, Elizabeth ^a,i   Medina, Rolando ^a,c   Raventos, Henriette ^b   Nicolini, Humberto ^d   Mendoza, Ricardo ^e   Ontiveros, Alfonso ^f   Jerez, Alvaro ^g   Muñoz, Rodrigo ^h   Dassori, Albana ^c   Escamilla, Michael ^a,i  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^d Grupo de Estudios Médicos y Familiares Carraci S C   (Mexico)

^e UCLA MEDICAL CENTER   (United States)

^f Instituto de Informacion de Investigacion en Salud Mental   (Mexico)

^g Centro de Investigacion   (Guatemala)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Alcohol; Drug abuse; Dual diagnosis; Latino populations; Schizophrenia; Substance misuse

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; CANNABIS ADDICTION; CENTRAL AMERICA; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DEPENDENCE; FEMALE; HISPANIC; HUMAN; IMMIGRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; UNEMPLOYMENT; CHI SQUARE DISTRIBUTION; CLASSIFICATION; FAMILY HEALTH; GENETICS; MIDDLE AGED; ONSET AGE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ADULT; AGE OF ONSET; CHI-SQUARE DISTRIBUTION; FAMILY HEALTH; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEX FACTORS; SOUTHWESTERN UNITED STATES; SUBSTANCE-RELATED DISORDERS;

EID: 77954094900     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.02.1053     Document Type: Article

References (46)

1. Addington J., Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr. Scand. 1997, 96(5):329-333.
2. Alegría M., Canino G., Shrout P.E., Woo M., Duan N., Vila D., Torres M., Chen C.N., Meng X.L. Prevalence of mental illness in immigrant and non-immigrant U.S. Latino groups. Am. J. Psychiatry. 2008, 165(3):359-569.
3. Alegria M., Canino G., Stinson F.S., Grant B.F. Nativity and DSM-IV psychiatric disorders among Puerto Ricans, Cuban Americans, and non-Latino whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry. 2006, 67(1):56-65.
4. Andrade L., Caraveo-Anduaja J.J., Berglund P., Bijl R.V., Kessler R.C., Demler O., Walters E.E., Kỳlỳc C., Offord D., Üstün T.B. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull. World Health Organ. 2000, 78(4):413-426.
5. Bartels S.J., Teague G.B., Drake R.E., Clark R.E., Bush P.W., Noordsy D.L. Substance abuse in schizophrenia: service utilization and costs. J. Nerv. Ment. Dis. 1993, 181(4):227-232.
6. Baumeister H., Härter M. Prevalence of mental disorders based on general population surveys. Soc. Psychiatry. Psychiatr. Epidemiol. 2007, 42(7):537-546.
7. Bijl R.V., Ravelli A., van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc. Psychiatry. Psychiatr. Epidemiol. 1998, 33(12):587-595.
8. Breslau J., Aguilar-Gaxiola S., Kendler K.S., Su M., Williams D., Kessler R.C. Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychol. Med. 2006, 36(1):57-68.
9. Buchanan R.L., Smokowski P.R. Pathways from acculturation stress to substance use among Latino adolescents. Subst. Use. Misuse. 2009, 44(5):740-762.
10. Cantor-Graae E., Nordström L.G., McNeil T.F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 2001, 48(1):69-82.
11. Chavarría-Siles I., Contreras-Rojas J., Hare E., Walss-Bass C., Quezada P., Dassori A., Contreras S., Medina R., Ramírez M., Salazar R., Raventos H., Escamilla M.A. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147(3):279-284.
12. Dervaux A., Baylé F.J., Laqueille X., Bourdel M.C., Le Borgne M.H., Olié J.P., Krebs M.O. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?. Am. J. Psychiatry. 2001, 158(3):492-494.
13. Dixon L., Haas G., Weiden P., Sweeney J., Frances A. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr. Bull. 1990, 16(1):69-79.
14. Escamilla M.A., Ontiveros A., Nicolini H., Raventos H., Mendoza R., Medina R., Munoz R., Levinson D., Peralta J.M., Dassori A., Almasy L. A genome-wide scan for schizophrenia and psychosis susceptibility loci in families of Mexican and Central American ancestry. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144(2):193-199.
15. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 1998, 24(3):443-455.
16. Gearon J.S., Nidecker M., Bellack A., Bennett M. Gender differences in drug use behavior in people with serious mental illnesses. Am. J. Addict. 2003, 12(3):229-241.
17. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Anderson K. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry. 2004, 61(12):1226-1233.
18. Jacobi F., Wittchen H.U., Holting C., Höfler M., Pfister H., Müller N., Lieb R. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol. Med. 2004, 34(4):597-611.
19. Kavanagh D.J., Waghorn G., Jenner L., Chant D.C., Carr V., Evans M., Hemnan H., Jablensky A., McGrath J.J. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr. Res. 2004, 66(2-3):115-124.
20. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 2005, 62(6):593-602.
21. Kessler R.C., Birnbaum H., Demler O., Falloon I.R., Gagnon E., Guyer M., Howes M.J., Kendler K.S., Shi L., Walters E., Wu E.Q. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol. Psychiatry. 2005, 58(8):668-676.
22. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994, 5(1):8-19.
23. Lammertink M., Löhrer F., Kaiser R., Hambrecht M., Pukrop R. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse. Acta Psychiatr. Scand. 2001, 104(5):361-366.
24. Levinson D.F., Mowry B.J., Escamilla M.A., Faraone S.V. The Lifetime Dimensions of Psychosis Scale (LDPS): description and interrater reliability. Schizophr. Bull. 2002, 2(4):683-695.
25. Maxwell M.E. The Family Interview for Genetic Studies: Manual. In: Clinical Neurogenetics Branch IRP 1992, National Institute of Mental Health, Washington, DC.
26. McCreadie R.G. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br. J. Psychiatry. 2002, 181(4):321-325.
27. Medina-Mora M.E., Borges G., Benjet C., Lara C., Berglund P. Psychiatric disorders in Mexico: lifetime prevalence in a nationally representative sample. Br. J. Psychiatry. 2007, 190(6):521-528.
28. Menezes P.R., Johnson S., Thornicroft G., Marshall J., Prosser D., Bebbington P., Kuipers E. Drug and alcohol problems among individuals with severe mental illness in south London. Br. J. Psychiatry. 1996, 168(5):612-619.
29. Montross L.P., Barrio C., Yamada A.M., Lindamer L., Golshan S., Garcia P., Fuentes D., Daly R.E., Hough R.L., Jeste D.V. Tri-ethnic variations of co-morbid substance and alcohol use disorders in schizophrenia. Schizophr. Res. 2005, 79(2-3):297-305.
30. Mueser K.T., Yarnold P.R., Rosenberg S.D., Swett C., Miles K.M., Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr. Bull 2000, 26(1):179-192.
31. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry. 1994, 51(11):849-859.
32. Padilla E., Padilla A., Morales A., Olmedo E. Inhalant, marijuana, and alcohol abuse among barrio children and adolescents. Int. J. Addict. 1979, 14(7):945-964.
33. Prado G., Huang S., Schwartz S.J., Maldonado-Molina M.M., Bandiera F.C., de la Rosa M., Patin H. What accounts for differences in substance use among U.S.-born and immigrant Hispanic adolescents?: results from a longitudinal prospective cohort study. J. Adolesc. Health. 2009, 45(2):118-125.
34. Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., Goodwin, F.K., 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 264 (19), 2511-2518.
35. Ringen P.A., Melle I., Birkenaes A.B., Engh J.A., Faerden A., Jónsdóttir H., Nesvåg R., Vaskinn A., Friis S., Larsen F., Opjordsmoen S., Sundet K., Andreassen O.A. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study. Acta Psychiatr. Scand. 2008, 117(2):133-138.
36. Rosenman S., Korten A., Medway J., Evans M. Characterising psychosis in the Australian National Survey of Mental Health and Wellbeing Study on Low Prevalence (psychotic) Disorders. Aust. N. Z. J. Psychiatry. 2000, 34(5):792-800.
37. Rossi Menezes P., Ratto L.R. Prevalence of substance misuse among individuals with severe mental illness in São Paulo. Soc. Psychiatry Psychiatr. Epidemiol. 2004, 39(3):212-217.
38. Sartorious N., Shapiro R., Kimura M., Barrett K. WHO international pilot study of schizophrenia. Psychol. Med. 1972, 2(4):422-425.
39. Soyka M., Albus M., Immler B., Kathmann N., Hippius H. Psychopathology in dual diagnosis and non-addicted schizophrenics-are there differences?. Eur. Arch. Psychiatry Clin. Neurosci. 2001, 251(5):232-238.
40. Swartz M.S., Wagner H.R., Swanson J.W., Stroup T.S., McEvoy J.P., Canive J.M., Miller D.D., Reimherr F., McGee M., Khan A., Van Dorn R., Rosenheck R.A., Lieberman J.A. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J. Nerv. Ment. Dis. 2006, 194(3):164-172.
41. Vega W.A., Canino G., Cao Z., Alegria M. Prevalence and correlates of dual diagnoses in U.S. Latinos. Drug and Alcohol Dependence. 2009, 100(1-2):32-38.
42. Vega W.A., Sribney W.M. Achara-Abrahams I. Co-occurring alcohol, drug, and other psychiatric disorders among Mexican-origin people in the United States. Am. J. Public. Health 2003, 93(7):1057-1064.
43. Vega W.A., Sribney W.M., Miskimen T.M., Escobar J.I., Aguilar-Gaxiola S. Putative psychotic symptoms in the Mexican American population: prevalence and co-occurrence with psychiatric disorders. J. Nerv. Ment. Dis. 2006, 194(7):471-477.
44. Verma S.K., Subramaniam M., Chong S.A., Kua E.H. Substance abuse in schizophrenia. A Singapore perspective. Soc. Psychiatry Psychiatr. Epidemiol. 2002, 37(7):326-328.
45. Weaver T., Renton A., Stimson G., Tyrer P. Severe mental illness and substance misuse. BMJ. 1999, 318(7177):137-138.
46. Zhang A.Y., Snowden L.R. Ethnic characteristics of mental disorders in five U.S. communities. Cultur. Divers. Ethnic. Minor. Psychol. 1999, 5(2):134-146.